Dose Exploration Study of GSK4532990 in Participants With NASH or Suspected NASH
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Drug: GSK4532990 Sponsors: GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alcoholism | Fatty Liver Disease (FLD) | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Research | Study | Urology & Nephrology